1. Treat-To-Target and Treat-To-Budget in Rheumatoid Arthritis: Measuring the Value of Individual Therapeutic Interventions

   • José A. Sacristán
   • Silvia Díaz
   • Alejandro Balsa

   Commentary Open access 30 October 2019 Pages: 473 - 477

2. New Insights in Physical Therapy and Rehabilitation in Axial Spondyloarthritis: A Review

   • Fabio Massimo Perrotta
   • Antonio Musto
   • Ennio Lubrano

   Review Open access 13 August 2019 Pages: 479 - 486

3. Assessing Physical Activity and Sleep in Axial Spondyloarthritis: Measuring the Gap

   • Atul Deodhar
   • Lianne S. Gensler
   • Philip J. Mease

   Review Open access 31 October 2019 Pages: 487 - 501

   

4. Two-Year Safety and Effectiveness of Peficitinib in Moderate-To-Severe Rheumatoid Arthritis: A Phase IIb, Open-Label Extension Study

   • Mark C. Genovese
   • Maria W. Greenwald
   • Alan J. Kivitz

   Original Research Open access 13 August 2019 Pages: 503 - 520

   

5. Sustained Very Low Disease Activity and Remission in Psoriatic Arthritis Patients

   • Ennio Lubrano
   • Fabio Massimo Perrotta
   • Philip Helliwell

   Original Research Open access 19 August 2019 Pages: 521 - 528

   

6. Comparative Disease Burden in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Axial Spondyloarthritis: Data from Two Corrona Registries

   • Philip J. Mease
   • Mei Liu
   • Jeffrey D. Greenberg

   Original Research Open access 16 September 2019 Pages: 529 - 542

   

7. A Randomized, Double-Blind, Non-Inferiority Study of Febuxostat Versus Allopurinol in Hyperuricemic Chinese Subjects With or Without Gout

   • Fengchun Zhang
   • Zhichun Liu
   • Shen Qu

   Original Research Open access 17 September 2019 Pages: 543 - 557

   

8. Efficacy of Abatacept and Adalimumab in Patients with Early Rheumatoid Arthritis With Multiple Poor Prognostic Factors: Post Hoc Analysis of a Randomized Controlled Clinical Trial (AMPLE)

   • Roy Fleischmann
   • Michael Weinblatt
   • Michael Schiff

   Original Research Open access 22 October 2019 Pages: 559 - 571

   

9. Real-World Comparative Effectiveness of Tofacitinib and Tumor Necrosis Factor Inhibitors as Monotherapy and Combination Therapy for Treatment of Rheumatoid Arthritis

   • George W. Reed
   • Robert A. Gerber
   • Gene Wallenstein

   Original Research Open access 09 November 2019 Pages: 573 - 586

   

10. Physical and Emotional Burden of Rheumatoid Arthritis: Data from RA Matters, a Web-Based Survey of Patients and Healthcare Professionals

    • Rieke Alten
    • Mart van de Laar
    • Ronald van Vollenhoven

    Original Research Open access 28 October 2019 Pages: 587 - 597

    

11. Risk of Potential Glucocorticoid-Related Adverse Events in Patients with Giant Cell Arteritis: Results from a USA-Based Electronic Health Records Database

    • Jennie H. Best
    • Amanda M. Kong
    • Margaret Michalska

    Original Research Open access 26 October 2019 Pages: 599 - 610

    

12. Changes in Opioid Utilization Following Tumor Necrosis Factor Inhibitor Initiation in Patients with Rheumatoid Arthritis

    • Siyeon Park
    • Tham T. Le
    • Eberechukwu Onukwugha

    Brief Report Open access 18 October 2019 Pages: 611 - 616